Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH dehydrogenase is a key enzyme in cellular respiration, specifically functioning as the first enzyme of the mitochondrial electron transport chain (Complex I). It catalyzes the oxidation of NADH to NAD+, transferring electrons from NADH to ubiquinone (coenzyme Q10), which is then reduced to ubiquinol. This process is coupled with proton translocation across the inner mitochondrial membrane, contributing to ATP synthesis via oxidative phosphorylation.
Inhibition of NADH oxidation and electron transfer to ubiquinone, disruption of proton gradient formation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH dehydrogenase [ubiquinone].